预测生物标志物和胃癌免疫疗法的新发展:2023年更新
1Department of Gastrointestinal Medical Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430079, Hubei, China.
American journal of cancer research
|August 10, 2023
概括
免疫检查点抑制剂在胃癌中表现有前途,特别是在具有特定生物标志物的患者中. 然而,确定免疫治疗的有效预测生物标志物仍然是一个重大挑战.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 胃癌是一种普遍存在的消化道瘤,预后通常不乐观.
- 虽然治疗的进步提高了生存率,但新的治疗策略至关重要.
研究的目的:
- 审查胃癌中抗PD-1/PD-L1治疗的预测生物标志物.
- 讨论涉及抗PD-1/PD-L1治疗胃癌的临床试验.
主要方法:
- 对胃癌免疫疗法预测生物标志物的文献综述.
- 对抗PD-1/PD-L1疗法的临床试验数据的分析.
主要成果:
- 免疫检查点抑制剂 (ICI) 提供了一个新的治疗选择,在一些胃癌患者中延长了生存时间.
- 患有高微卫星不稳定性,爱斯坦-巴尔病毒阳性状态或高瘤突变负担的患者可能受益于免疫治疗.
- 缺乏统一和有效的预测标记阻碍了最佳的患者选择.
结论:
- 免疫疗法是胃癌治疗的一个有前途的方法.
- 将免疫疗法与其他疗法结合起来可能是未来的趋势.
- 开发可靠的生物标志物来预测ICI反应是一个至关重要的未满足的需求.
相关概念视频
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Cancer Vaccines
403
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


